ENTITY

Collplant Biotechnologies (CLGN US)

Analysis

Health Care • Israel

CollPlant Biotechnologies Ltd. operates as a regenerative medicine company. The Company focuses on the 3D bioprinting of tissues and organs, as well as on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00